In this episode of the podcast, Joe interviews Greg McKee: Chairman and CEO of Tryp Therapeutics, an early-stage biotech …
1 Comment
Yet another market/profit minded pharma exec.
A question you should ask these types is "Are you interested in the liberalisation of those modalities of healing even if it means your investment will fail or is your investment a means to an end, that end being making money?"
Yet another market/profit minded pharma exec.
A question you should ask these types is "Are you interested in the liberalisation of those modalities of healing even if it means your investment will fail or is your investment a means to an end, that end being making money?"